-+ 0.00%
-+ 0.00%
-+ 0.00%

NRX PHARMACEUTICALS, INC. (NASDAQ:NRXP) ANNOUNCES FILING OF COMMISSIONER'S NATIONAL PRIORITY VOUCHER APPLICATION FOR INTRAVENOUS KETAMINE (NRX-100)

Reuters·06/23/2025 12:03:43

Please log in to view news